iDOVE: Durability of Vaccine Efficacy Against SARS-CoV-2 Infection
Implements a nonparametric maximum likelihood method for assessing
potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection
under staggered enrollment and time-varying community transmission, allowing
crossover of placebo volunteers to the vaccine arm.
Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021)
<doi:10.1093/cid/ciab630>.
| Version: |
1.4 |
| Depends: |
R (≥ 3.5.0) |
| Imports: |
Rcpp (≥ 1.0.4.6), methods, stats, graphics |
| LinkingTo: |
Rcpp, RcppArmadillo |
| Suggests: |
rmarkdown, knitr |
| Published: |
2022-06-07 |
| Author: |
Yu Gu [aut],
Shannon T. Holloway [aut, cre],
Dan-Yu Lin [aut] |
| Maintainer: |
Shannon T. Holloway <shannon.t.holloway at gmail.com> |
| License: |
GPL-2 |
| NeedsCompilation: |
yes |
| Materials: |
NEWS |
| CRAN checks: |
iDOVE results |
Documentation:
Downloads:
Linking:
Please use the canonical form
https://CRAN.R-project.org/package=iDOVE
to link to this page.